STMC-103H

STMC-103H · Siolta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STMC-103H, covering 2019-01-29 to 2019-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy [Phase 1]